微信公众号「张强医疗科技」

关于张强医生集团

张强医生集团(Dr. Smile Medical Group)成立于2014年7月1日,总部位于上海,法人机构为上海张强医疗科技股份有限公司,为中国首家医生集团,创始人为我国著名血管外科专家张强医生。目前集团在上海、北京、深圳、成都、广州等城市拥有亚洲最大连锁下肢静脉曲张治疗中心。

张强医生集团是首个发起和参与负责全球专项临床技术—CHIVA国际认证的中国医生团队,同时属于国家级静脉病专业委员会的主委单位,并负责主办静脉病国家级医学继续教育项目。作为国际静脉病论坛(GVF)、思俊国际静脉病学院线上教育主办方,张强医生团队在国内最早引入和应用多项静脉曲张治疗技术,包括内镜(SEPS)、静脉腔内射频消融、CHIVA等。

张强医生集团成功将传统下肢静脉曲张可能长达数天的住院治疗,缩短成为一小时左右的CHIVA门诊治疗,目前下肢静脉曲张微创治疗已服务两万余例,2021年患者满意度超过98.2%。

Dr. Smile Medical Group, founded on July 1, 2014, is the first medical group in China, founded by Dr. Smile, a renowned vascular surgeon in China, with its headquarters in Shanghai, China.

 In 2013, Dr. Smile established the first vein center in China, focusing on the diagnosis and treatment of varicose veins, venous thrombosis, venous ulcers and other venous diseases of the lower limbs. Now we have vein center in Shanghai, Beijing, Shenzhen, Chengdu, Guangzhou etc., and we are the largest chain of lower limb varicose veins treatment centers in Asia. Dr. Smile Medical Group has a professional team of phlebology specialists and the cutting-edge CHIVA minimally invasive treatment technology for varicose veins, which has treated more than 20,000 cases of varicose veins at home and abroad, making it at the forefront of the world.

 Meanwhile, Dr. Smile Medical Group has also established an international academic platform and cooperated with medical specialists from the United States, France, Italy, Japan, etc., to carry out technological innovation in varicose veins treatment and relevant medical instruments development.

 Dr. Smile Medical Group is the first medical group in Chinese medical field responsible for the international certification of global specialized medical clinical techniques, and also belongs to the main unit of the national professional committee for venous diseases, and has the qualification of national medical continuing education project. Meanwhile, as the host of Global Venous ForumGVF, one of the three major academic platforms for venous diseases in the world. Dr. Smile Medical Group was earliest in China to introduce and implement several technologies for the treatment of varicose veins in the lower limbs, including SEPS, radiofrequency ablation, and CHIVA, etc.

 Through the study of venous hemodynamics and the application of CHIVA, Dr. Smile Medical Group successfully shortened the traditional inpatient treatment of varicose veins in the lower limbs, which may take several days, into an outpatient treatment that takes about an hour, minimizing the complications of traditional surgery and saving a lot of time and subsequent recovery process for patients. More than 98.2% patient satisfaction in 2021.

 Dr. Smile is the founder of the Chinese medical group. Known as an expert in vascular surgery and a leader in the field of venous disease, Dr. Smile has continued to explore and innovate in his specialized field and pursued excellence, and has served as the director of vascular surgery in three public Grade A tertiary hospitals. He always strives to achieve the ultimate in phlebology, and eventually went outside the institution and successfully founded the first medical group in China.

 In August 2014, Dr. Smile Medical Group proposed the physician-hospital partnership (PHP) model for the first time in China.

 In June 2015, completed the shareholding reform.

 In February 2016, completed the first round of Pre-A financing.

 In March 2016, launched and established the Chinese medical group.

In October 2016, established the shared model vein center.

 In December 2016, won the “Oscar” of China’s medical and health industry, the CHIP Award.

 In February 2017, DR. SMILE MEDICAL GROUP was registered in the U.S.

 In August 2017, Dr. Smile Surgical Clinic, a chain of medical institutions under Dr. Smile Medical Group, was landed. After that, Surgeon Club and Surgeon Venous Disease Academy were established, and a national professional committee for the venous diseases was initiated and set up.

 In December 2018, won the “Top 10 Medical Group Brands” at Shanghai Medical Fair.

 In April 2019, hosted the Global Venous Forum (GVF) and published the first Asian Consensus on the CHIVA Treatment of Varicose Veins.

 In May 2021, signed a long-term strategic cooperation memorandum with Inteleos, a global medical certification organization, and launched the global CHIVA certification project, which is a remarkable milestone.

 In the future, Dr. Smile Medical Group will collaborate with more excellent doctors from all over the world and become the international leader in the specialized treatment of venous diseases.

医生集团又称为“医生执业团体”或者“医生执业组织”,是有多个医生团队组成的联盟或者组织机构,英文名为“Medical Group”。医生集团是独立于医院之外的医生组织,和签约医疗机构或者在自营医疗机构提供医疗服务。 

医生团体执业的开创者是世界著名的梅奥诊所。签约医生集团,是世界上大多数发达国家和地区的医生执业方式。美国医疗协会(American Medical Association) 2012年的报告统计, 5.6%的医生直接受雇于医院、是医院的雇员,83%的美国医生加入“医生集团”。

中国医生集团奠基人,静脉病领域著名专家,优质医疗倡导者。主任医师,教授,硕士生导师。中国医生集团联盟首任主席、永久名誉主席,思俊静脉病学院院长,中国老年保健协会静脉病专委会主任委员。民建中央人口医药卫生委员会委员,民建上海市委医卫委员会执行主任,五四青年奖章获得者,《健康中国》年度风尚人物。中国首批医疗健康管理EMBA学位项目、中荷国际工商管理学院客座教授。先后负责创办了浙江大学附属邵逸夫医院血管外科、杭州市血管外科中心和上海同济大学附属东方医院血管外科。2012年12月,张强医生正式宣布离开体制,组建静脉病专科团队。2014年7月1日,宣布成立张强医生集团(Dr. Smile Medical Group),从此开创中国医生集团的先河。

张强医生集团国际静脉病中心(Dr. Smile Medical Group International Vein Center, SIVC )为国内第一个专注于静脉系统疾病诊疗的专科中心。在著名静脉病专家张强医生领衔下,聚集一批京沪等地三甲医院走出体制的优秀医生团队,多位医生具欧美学习背景。

张强医生团队在下肢静脉曲张诊疗领域持续创新,拥有多项亚洲和国内技术及纪录,引领学术前沿:

1997年,在亚洲地区首先开展内镜技术治疗静脉性溃疡(SEPS),突破顽固性溃疡的治疗难题;

2002年,全球首例腔内钬激光治疗下肢静脉曲张手术,拓展了钬激光在血管外科领域的应用;

2010年,国内率先开展下肢静脉曲张日间手术,改变了静脉曲张手术需要住院的传统历史;

2011年,开展中国首例静脉曲张CHIVA手术治疗,引入了保留静脉的治疗理念;

2015年,开展中国首例ClosureFast静脉腔内射频闭合术;

2015年,下肢静脉曲张日间手术量居全国首位;

2016年,开展全球首例VR辅助局麻下静脉曲张手术;

2017年,开展下肢静脉曲张的血流动力学诊断和评估,采用CHIVA门诊治疗全面取代以往的静脉破坏性手术;

2018年,发起并成立了国家级静脉病专业委员会,搭建学术交流平台;

2019年,主办首届国际静脉病论坛,并发布了亚洲首个《静脉曲张CHIVA诊疗共识》;

2020年,主办第二届国际静脉病论坛。

张强医生集团国际静脉病中心(SIVC)由自营机构(思俊外科诊所)、签约医院以及专门面向静脉病患者的在线服务平台组成,把国际前沿的治疗技术、诊疗服务模式和国际静脉病专家带给中国患者,让中国的静脉病患者能享受到先进的专科医疗服务。

SIVC目前已经落地于全国多座城市:上海、北京、广州、成都、杭州、深圳、西安、南京、青岛、沈阳、重庆。

2014年7月,宣布成立张强医生集团

2014年8月,张强医生集团在国内首次提出医生和医院合作的PHP模式;

2015年6月,完成股份制改革;

2016年3月,发起并成立中国医生集团联盟;

2016年10月,多个城市建立共享型静脉病中心;

2016年12月,荣获中国医疗健康产业“奥斯卡”奇璞奖;

2017年2月,DR.SMILE MEDICAL GROUP在美国注册;

2017年8月,建立张强医生集团旗下连锁外科诊所,发起并成立国家级静脉病专业委员会。

2018年12月,荣获上海医交会“十大医生集团品牌”;

2019年4月,主办国际静脉病论坛(GVF),并发布了亚洲《静脉曲张CHIVA诊疗共识》;

2020年2月,提出互联网诊断学,开启“空中门诊”;

2021年05月,与全球医学认证机构Inteleos签署长期战略合作备忘录并启动全球CHIVA认证项目;

2022年,参编国际静脉病专业书籍出版;全球CHIVA认证项目顺利推进一周年;

使   命:让人人享有优质医疗

愿   景:做最好的专科团队

价值观:尊重,协同,创新,坚定

关闭菜单